1,109
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluations

Insulin degludec/liraglutide: innovation-driven combination for advancement in diabetes therapy

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Mingyan Cao, Niluka De Mel, Anthony Shannon, Meagan Prophet, Chunlei Wang, Weichen Xu, Ben Niu, Jun Kim, Methal Albarghouthi, Dengfeng Liu, Eric Meinke, Shihua Lin, Xiangyang Wang & Jihong Wang. (2019) Charge variants characterization and release assay development for co-formulated antibodies as a combination therapy. mAbs 11:3, pages 489-499.
Read now
Suhaj Abdulsalim, Munawar Peringadi Vayalil & Sonal Sekhar Miraj. (2016) New fixed dose chemical combinations: the way forward for better diabetes type II management?. Expert Opinion on Pharmacotherapy 17:16, pages 2207-2214.
Read now
André J. Scheen. (2016) Investigational insulin secretagogues for type 2 diabetes. Expert Opinion on Investigational Drugs 25:4, pages 405-422.
Read now
Charles F. Shaefer & John Anderson. (2016) The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin. Postgraduate Medicine 128:1, pages 137-144.
Read now
Frank Lavernia, Sarah E. Adkins & Jay H. Shubrook. (2015) Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goals. Postgraduate Medicine 127:8, pages 808-817.
Read now

Articles from other publishers (8)

Hao Lou & Michael J. Hageman. (2022) Development of an In Vitro System To Emulate an In Vivo Subcutaneous Environment: Small Molecule Drug Assessment. Molecular Pharmaceutics 19:11, pages 4017-4025.
Crossref
Hao Lou, Mei Feng & Michael J. Hageman. (2022) Advanced Formulations/Drug Delivery Systems for Subcutaneous Delivery of Protein-Based Biotherapeutics. Journal of Pharmaceutical Sciences 111:11, pages 2968-2982.
Crossref
Arnaldo Moura Neto & Maria Tereza Martins Ferrari. (2018) Efficacy, safety and clinical use of newer basal insulins analogs. Endocrinology&Metabolism International Journal 6:3.
Crossref
Claudia Mueller, Ulrike Altenburger & Silke Mohl. (2018) Challenges for the pharmaceutical technical development of protein coformulations. Journal of Pharmacy and Pharmacology 70:5, pages 666-674.
Crossref
Joseph S. Redman, J. Nicholas Francis, Robert Marquardt, Damon Papac, Alan L. Mueller, Debra M. Eckert, Brett D. Welch & Michael S. Kay. (2018) Pharmacokinetic and Chemical Synthesis Optimization of a Potent d -Peptide HIV Entry Inhibitor Suitable for Extended-Release Delivery . Molecular Pharmaceutics 15:3, pages 1169-1179.
Crossref
Thomas Forst & Christoph KaptizaJochen Seufert. 2015. Clinical Advances in Diabetes Mellitus. Clinical Advances in Diabetes Mellitus 34 49 .
Sarah L. Greig & Lesley J. Scott. (2015) Insulin Degludec/Liraglutide: A Review in Type 2 Diabetes. Drugs 75:13, pages 1523-1534.
Crossref
Jiten Vora, Bertrand Cariou, Marc Evans, Jorge Luiz Gross, Stewart Harris, Lena Landstedt-Hallin, Ambrish Mithal, Martín Rodríguez Rodriguez & Luigi Meneghini. (2015) Clinical use of insulin degludec. Diabetes Research and Clinical Practice 109:1, pages 19-31.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.